相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination regimen with statins and NSAIDs: A promising strategy for cancer chemoprevention
Hang Xiao et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Novel combination treatment of type 2 diabetes DPP-4 inhibition
Bo Ahren
VASCULAR HEALTH AND RISK MANAGEMENT (2008)
Proteins, drug targets and the mechanisms they control: the simple truth about complex networks
Robyn P. Araujo et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
How to design multi-target drugs: target search options in cellular networks
Tamas Korcsmaros et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
Dynamic simulations on the arachidonic acid metabolic network
Kun Yang et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Natalie C. Duarte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chemical combination effects predict connectivity in biological systems
Joseph Lehar et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis
Cristina Vidal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
Innovation - A robustness-based approach to systems-oriented drug design
Hiroaki Kitano
NATURE REVIEWS DRUG DISCOVERY (2007)
The lipoxygenase-cyclooxygenase inhibitor licofelone prevents thromboxane A2-mediated cardiovascular derangement triggered by the inflammatory peptide fMLP in the rabbit
Serenella Rotondo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Can we rationally design promiscuous drugs?
AL Hopkins et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action
B Ganter et al.
JOURNAL OF BIOTECHNOLOGY (2005)
Systems modeling: a pathway to drug discovery
P Rajasethupathy et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Genetic diversity and new therapeutic concepts
BS Shastry
JOURNAL OF HUMAN GENETICS (2005)
Cardiovascular hazard and non-steroidal anti-inflammatory drugs
DR Wong et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Automated oncogene detection in complex protein networks with applications to the MAPK signal transduction pathway
D Pant et al.
BIOPHYSICAL CHEMISTRY (2005)
Target-based drug discovery: is something wrong?
F Sams-Dodd
DRUG DISCOVERY TODAY (2005)
Prostaglandin E2 as a mediator of fever:: Synthesis and catabolism
AI Ivanov et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: Results from a randomized, controlled trial
P Bias et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
A physical and functional map of the human TNF-α NF-κB signal transduction pathway
T Bouwmeester et al.
NATURE CELL BIOLOGY (2004)
From large networks to small molecules
JR Sharom et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Licofelone - clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis
JM Alvaro-Gracia
RHEUMATOLOGY (2004)
Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice
T Kobayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
MPGES-1 as a novel target for arthritis
H Fahmi
CURRENT OPINION IN RHEUMATOLOGY (2004)
Predicting the risk for gastrointestinal toxicity in patients taking NSAIDs: The Gastrointestinal Toxicity Survey
A Ambegaonkar et al.
ADVANCES IN THERAPY (2004)
Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis
JZ Haeggström
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
In silico simulation of inhibitor drug effects on nuclear factor-κB pathway dynamics
MH Sung et al.
MOLECULAR PHARMACOLOGY (2004)
Development of human protein reference database as an initial platform for approaching systems biology in humans
S Peri et al.
GENOME RESEARCH (2003)
Innovation - Target discovery
MA Lindsay
NATURE REVIEWS DRUG DISCOVERY (2003)
Systematic discovery of multicomponent therapeutics
AA Borisy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Comparison of once-daily, niacin extended/release/lovastatin with standard doses of atorvastatin and simvastafin (The Advicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE])
HE Bays et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors
B Schoeberl et al.
NATURE BIOTECHNOLOGY (2002)
Cyclooxygenase-selective inhibition of prostanoid formation:: transducing biochemical selectivity into clinical read-outs
C Patrono et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Advair: Combination treatment with fluticasone propionate/salmeterol in the treatment of asthma
HS Nelson
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
分享论文
